|
|
.
See Category: Neoplasms
See Header: Benign carcinoid tumors of the appendix, lg int, and rectum
ICD-10 (CM) Code and Descriptor
|
D3A.029 |
Benign carcinoid tumor of the large intestine, unspecified portion
|
D3A029 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 43.46%
|
19.29%
|
10.20%
|
11.09%
|
3.99%
|
3.99%
|
1.55%
|
2.00%
|
0.89%
|
1.11%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D3A.029*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
69
|
70
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
66
|
66
|
|
80053
|
COMPREHEN METABOLIC PANEL |
63
|
63
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
63
|
64
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
56
|
56
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
51
|
51
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
43
|
1,120
|
|
97530
|
THERAPEUTIC ACTIVITIES |
29
|
66
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
24
|
2,536
|
|
97110
|
THERAPEUTIC EXERCISES |
23
|
31
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
23
|
23
|
|
J1930
|
LANREOTIDE INJECTION |
21
|
2,520
|
|
71260
|
CT THORAX DX C+ |
14
|
14
|
|
82565
|
ASSAY OF CREATININE |
11
|
11
|
|
84443
|
ASSAY THYROID STIM HORMONE |
10
|
10
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
9
|
155
|
|
85027
|
COMPLETE CBC AUTOMATED |
9
|
9
|
|
83497
|
ASSAY OF 5-HIAA |
9
|
9
|
|
J1170
|
HYDROMORPHONE INJECTION |
8
|
39
|
|
84260
|
ASSAY OF SEROTONIN |
8
|
8
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D3A.029 related to the following DRG Codes:
393-395
|
